B-CELLS FROM A DISTINCT SUBSET OF PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY (CVID) HAVE INCREASED CD95 (APO-1 FAS), DIMINISHED CD38 EXPRESSION, AND UNDERGO ENHANCED APOPTOSIS/
A. Saxon et al., B-CELLS FROM A DISTINCT SUBSET OF PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY (CVID) HAVE INCREASED CD95 (APO-1 FAS), DIMINISHED CD38 EXPRESSION, AND UNDERGO ENHANCED APOPTOSIS/, Clinical and experimental immunology, 102(1), 1995, pp. 17-25
We investigated the role of apoptosis in the differentiation failure o
f B cells from a selected subpopulation of patients with CVID delineat
ed by B cell surface marker analysis, in vitro ISE response, and molec
ular markers of B cell V-H gene repertoire. These patients had altered
display of B cell surface molecules that play a role in apoptosis. Th
e patients' B cells had a 4.5-250-fold increase in CD95 (Apo-1, fas) e
xpression and increased CD95 display on their T cells. CD38, a molecul
e important in preventing germinal centre B cell apoptosis, was reduce
d on the patients' B cells. The expression of this molecule was induci
ble on the CVID lymphocytes with retinoic acid. Increased spontaneous
apoptosis in vitro was observed with the patients' B (23%) and T cells
(10%) compared with normal cells (13% and 3%, respectively). Stimulat
ion in vitro with IL-4 and CD40 rescued the B cells from apoptosis and
allowed for their differentiation. However, IL-4 plus alpha CD40-driv
en immunoglobulin production was not quantitatively or qualitatively n
ormal. Failure to overcome apoptosis, a normal step in germinal centre
B cell development, may be involved in the lack of differentiation se
en in this subset of CVID patients.